All of us at RadNet Leeds are delighted with the award of a Lifetime Achievement Award by the European Society for Radiotherapy and Oncology (ESTRO) to our Director, Professor David Sebag-Montefiore.
Over 40 years, David has made a remarkable contribution to rectal and anal cancer research, and treated thousands of patients with radiotherapy. Typically modest, David said: “I’m deeply humbled to receive the award and to be recognised by my peers. None of this work is possible without collaboration and without great minds to work with, so I also consider it as acknowledgement of the brilliant teams I work with too. It is a great privilege to work with outstanding people, in Leeds, in Yorkshire and internationally.”
David went on to explain how exciting the outlook is for cancer research and treatment:
“Within the next 10 years, I think we’ll be able to say to a newly diagnosed patient not only that we know how to treat their cancer with radiotherapy, but we know the right dose, and whether they are likely to need additional treatment like new drugs or immunotherapy.
“The research we’re doing now will show us the best treatment for each patient, and our clinical trials will tell us how well these new treatments are working.
“A patient with cancer at the start of my career would have a vastly different experience if they were diagnosed today. And it’s very exciting to know that in future we can go even further.”
Congratulations, David!